The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[(E)-2-chloro-benzenesulfonylimino]-imidazolidine-1-carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester ID: ALA377035
PubChem CID: 16038016
Max Phase: Preclinical
Molecular Formula: C14H13ClN6O2S5
Molecular Weight: 493.09
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(NC1=NCCN1C(=S)SN1CCn2c1nsc2=S)c1ccccc1Cl
Standard InChI: InChI=1S/C14H13ClN6O2S5/c15-9-3-1-2-4-10(9)28(22,23)18-11-16-5-6-19(11)14(25)27-21-8-7-20-12(21)17-26-13(20)24/h1-4H,5-8H2,(H,16,18)
Standard InChI Key: AVPKOUBDQYTMQB-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
9.8193 -19.0534 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5919 -19.3503 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.1112 -18.7094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8647 -18.2322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6633 -18.0162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7049 -17.1911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9323 -16.8943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4130 -17.5390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9363 -18.7510 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5918 -17.4937 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.1766 -16.7803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3537 -16.7803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5918 -16.0669 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.8673 -16.1139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0821 -16.3689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0821 -17.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8673 -17.4466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1223 -18.2319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5358 -18.8184 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.1223 -19.4011 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9531 -18.2319 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9531 -19.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1604 -19.1863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5781 -19.7682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7912 -20.5651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5919 -20.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1709 -20.1935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9666 -20.4024 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
3 9 2 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 12 1 0
17 18 1 0
18 19 1 0
19 20 2 0
19 21 2 0
19 22 1 0
22 23 2 0
1 2 1 0
23 24 1 0
2 3 1 0
24 25 2 0
3 5 1 0
25 26 1 0
4 1 2 0
26 27 2 0
27 22 1 0
4 5 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 493.09Molecular Weight (Monoisotopic): 491.9392AlogP: 2.73#Rotatable Bonds: 3Polar Surface Area: 82.83Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.67CX Basic pKa: 1.61CX LogP: 4.37CX LogD: 4.35Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.83
References 1. Saczewski J, Brzozowski Z, Saczewski F, Bednarski PJ, Liebeke M, Gdaniec M.. (2006) Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides., 16 (14): [PMID:16682194 ] [10.1016/j.bmcl.2006.04.067 ]